| Fluid delivery apparatus having a controller assembly and method of use |
2022-5-05 |
2022-11-10 |
|
| Microneedle array assembly and fluid delivery apparatus having such an assembly |
2022-3-21 |
2022-7-07 |
|
| Microneedle array assembly and fluid delivery apparatus having such an assembly |
2022-3-21 |
2023-9-05 |
2023-9-05 |
| Dimeric Antigen Receptors (DAR) that Bind BCMA |
2022-3-03 |
2022-8-11 |
|
| Chemically-Locked Bispecific Antibodies |
2022-1-26 |
2022-5-12 |
|
| Formulation of Resiniferatoxin |
2022-1-05 |
2022-11-24 |
|
| Transdermal drug delivery apparatus and methods |
2021-12-28 |
2022-10-20 |
|
| Methods of treating pain |
2021-12-27 |
2022-6-30 |
|
| Antigen Binding Proteins that Bind PD-1 |
2021-12-17 |
2022-8-04 |
|
| Method for administering a medicament suitable for treating a migraine or … |
2021-11-30 |
2022-3-17 |
|
| CD38 Antibody Drug Conjugate |
2021-11-03 |
2022-4-21 |
|
| Microneedle array assembly, drug delivery device and method for administering … |
2021-10-25 |
2022-2-10 |
|
| Nanopatterned medical device with enhanced cellular interaction |
2021-10-19 |
2022-2-10 |
|
| Antibody therapeutics that bind cd137 |
2021-10-12 |
2022-1-27 |
|
| Oral delayed burst formulation of low-dose naltrexone or naloxone used for … |
2021-10-05 |
2023-8-16 |
|
| Antibody Therapeutics that Bind CTLA4 |
2021-9-22 |
2022-1-06 |
|
| Antigen Binding Proteins that Bind c-Met |
2021-9-22 |
2022-1-06 |
|
| MEDICAL DEVICES FOR DELIVERY OF siRNA |
2021-9-01 |
2021-12-23 |
|
| Antigen Binding Proteins that Bind BCMA |
2021-8-25 |
2021-12-16 |
|
| Transdermal delivery of high viscosity bioactive agents |
2021-8-23 |
2022-1-13 |
|
| Variant antibodies that bind ox40 |
2021-8-23 |
2021-12-23 |
|
| Implantable devices for delivery of bioactive agents |
2021-8-02 |
2021-12-30 |
|
| Fully Human Antibodies That Bind to Vascular Endothelial Growth Factor Receptor … |
2021-7-29 |
2022-1-27 |
|
| Perineural Administration of Resiniferatoxin for Treatment of Maladaptive Pain |
2021-6-11 |
2021-12-23 |
|
| Methods for Treating Parkinson?s Disease by Administering Resiniferatoxin |
2021-6-11 |
2021-9-30 |
|
| Antigen Binding Proteins That Bind PD-L1 |
2021-5-03 |
2021-10-28 |
|
| Antibody Drug Conjugates Having Derivatives of Amatoxin As The Drug |
2021-4-26 |
2021-8-26 |
|
| Transdermal drug delivery device |
2021-2-18 |
2021-6-10 |
|
| Cartridge portion of transdermal drug delivery apparatus and methods |
2021-2-03 |
2021-7-01 |
|
| Antibody therapeutics that bind CD123 |
2021-1-15 |
2023-9-05 |
2023-9-05 |
| Antibody therapeutics that bind cd123 |
2021-1-15 |
2021-6-03 |
|
| Antigen Binding Proteins that Bind PD-L1 |
2021-1-13 |
2021-5-20 |
|
| Fluid delivery apparatus having a gas extraction device and method of use |
2020-12-22 |
2021-4-15 |
|
| Variant Antibody That Binds Cd38 |
2020-12-18 |
2021-5-06 |
|
| Compositions and Methods Comprising an Anti-CD47 Antibody in Combination with a … |
2020-12-04 |
2021-7-22 |
|
| Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 … |
2020-12-04 |
2023-1-05 |
|
| Drug-Conjugates With a Targeting Molecule and Two Different Drugs |
2020-9-29 |
2021-1-21 |
|
| Methods for better delivery of active agents to tumors |
2020-9-16 |
2021-2-25 |
|
| Antibody Therapeutics that Bind CD38 |
2020-9-09 |
2020-12-24 |
|
| Dimeric Antigen Receptors |
2020-9-04 |
2020-12-24 |
|
| Disulfide Bridging Conjugates |
2020-8-31 |
2021-2-25 |
|
| Anti-ox40 binding proteins |
2020-8-17 |
2020-12-10 |
|
| Increased bioavailability of transdermally delivered agents |
2020-8-13 |
2020-12-10 |
|
| Oral composition of celecoxib for treatment of pain |
2020-7-24 |
2020-11-12 |
|
| Methods for lymphatic delivery of active agents |
2020-7-10 |
2020-10-29 |
|
| Heterodimeric Antibodies That Bind to CD38 and CD3 |
2020-6-30 |
2022-11-17 |
|
| Device for delivery of rheumatoid arthritis medication |
2020-6-09 |
2020-9-24 |
|
| Activatable Multi-Specific Antigen Binding Protein Complexes |
2020-4-10 |
2022-10-13 |
|
| Cannabidiol Pharmaceutical Compositions |
2020-4-03 |
2022-6-16 |
|
| Engineered Variant Antibodies that Bind CD38 |
2020-3-27 |
2022-5-12 |
|
| Improved process for integration of dna constructs using rna-guided … |
2020-3-11 |
2022-5-12 |
|
| Improved process for dna integration using rna-guided endonucleases |
2020-2-27 |
2022-6-02 |
|
| Fluid delivery apparatus and method of assembly |
2020-2-25 |
2020-9-03 |
|
| Method for Treating Osteoarthritis Pain by Administering Resiniferatoxin |
2020-1-21 |
2022-3-31 |
|
| Cell internalizing compounds |
2019-6-27 |
2019-11-28 |
|
| Drug delivery methods targeting the lymphatic system |
2019-5-30 |
2021-7-29 |
|
| Method for increasing permeability of a cellular layer of epithelial cells |
2019-5-24 |
2021-8-10 |
2021-8-10 |
| Anti-KRAS binding proteins |
2019-4-10 |
2021-11-16 |
2021-11-16 |
| Antigen binding proteins that bind wisp1 |
2019-4-03 |
2019-7-25 |
|
| Oral composition of celecoxib for treatment of pain |
2019-3-29 |
2019-7-25 |
|
| Methods for blocking an interaction between notch-1 and delta-like 4 (DLL-4) by … |
2019-1-07 |
2020-7-21 |
2020-7-21 |
| Variant antibodies that bind aip2 |
2018-12-20 |
2019-6-27 |
|
| CD-38 Directed Chimeric Antigen Receptor Constructs |
2018-11-02 |
2019-5-09 |
|
| Fully human anti-C-X-C chemokine receptor 3 (CXCR3) antibodies and methods of … |
2018-10-09 |
2020-6-02 |
2020-6-02 |
| Anti-cancer phosphorothioate-coupled peptide conjugates and methods of using … |
2018-7-13 |
2021-5-27 |
|
| Antigen binding proteins that bind CCR2 |
2018-3-19 |
2020-6-30 |
2020-6-30 |
| Pharmaceutical formulation |
2018-2-27 |
2018-7-05 |
|
| Cell penetrating peptide inhibitors of p53-MDM2 interaction |
2018-1-25 |
2020-3-10 |
2020-3-10 |
| Antibody therapeutics that bind TIM3 |
2017-12-14 |
2021-2-23 |
2021-2-23 |
| Application device for a fluid delivery apparatus and method of use |
2017-12-05 |
2023-2-14 |
2023-2-14 |
| Attachment band for a fluid delivery apparatus and method of use |
2017-12-05 |
2022-1-11 |
2022-1-11 |
| Pharmaceutical formulation |
2017-10-30 |
2018-8-23 |
|
| Fully human anti-cxc chemokine receptor 5 (cxcr5) antibodies |
2017-8-10 |
2017-11-30 |
|
| Antibody therapeutics that bind stat3 |
2017-4-25 |
2017-10-26 |
|
| Anti-infective binding proteins that bind AIP2 |
2017-3-17 |
2019-11-12 |
2019-11-12 |
| Intracellular delivery compounds |
2016-10-20 |
2019-7-02 |
2019-7-02 |
| Antibody therapeutics that bind LAG3 |
2016-7-22 |
2018-2-27 |
2018-2-27 |
| Antigen Binding Proteins that Bind ErbB3 |
2016-4-28 |
2016-10-27 |
|
| Antibody Therapeutics That Bind CD123 |
2016-4-08 |
2016-10-13 |
|
| Antibody therapeutics that bind psma |
2016-3-10 |
2016-11-10 |
|
| Antibody therapeutics that bind JAG1 |
2016-3-07 |
2019-10-08 |
2019-10-08 |
| Antibody therapeutics that bind cd47 |
2016-3-04 |
2016-9-08 |
|
| Antibody Drug Conjugates |
2016-1-28 |
2017-7-06 |
|
| Antibody Therapeutics That Bind OprF and Oprl |
2015-8-28 |
2016-3-03 |
|
| Chemically-locked bispecific antibodies |
2015-5-10 |
2019-10-08 |
2019-10-08 |
| Draped microneedle array |
2015-4-29 |
2018-5-08 |
2018-5-08 |
| Receptacle portion of transdermal drug delivery apparatus and methods |
2015-4-29 |
2017-2-16 |
|
| Controller portion of transdermal drug delivery apparatus and methods |
2015-4-29 |
2019-6-25 |
2019-6-25 |
| Antibody therapeutics that bind cd147 |
2015-4-14 |
2017-2-09 |
|
| Small molecule c-myc inhibitors |
2014-12-10 |
2016-9-15 |
|
| Microneedles with improved open channel cross-sectional geometries |
2014-5-20 |
2017-10-24 |
2017-10-24 |
| Drug delivery device |
2014-2-28 |
2018-1-09 |
2018-1-09 |
| Antigen Binding Proteins that Bind IGF1R |
2013-6-12 |
2013-12-26 |
|
| Antibodies that bind epidermal growth factor receptor (EGFR) |
2013-5-13 |
2018-4-17 |
2018-4-17 |
| Transdermal Device Containing Microneedles |
2011-6-10 |
2012-12-13 |
|
| Transdermal Patch Containing Microneedles |
2011-2-28 |
2012-8-30 |
|